{"entity":{"type":"insider","cik":"0001503681","url":"/insider/0001503681","json_url":"/insider/0001503681.json","name":"Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2010-10-27","last":"2014-02-13","span_basis":"filed_date"},"name_variants":[{"name":"Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.","source":"filing","n_filings":5,"first_seen":"2010-10-27","last_seen":"2014-02-13"}],"transactions":[{"id":6663976,"accession":"0001104659-14-009592","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-14-009592","line_url":"/filing/0001104659-14-009592","is_derivative":false,"issuer_cik":"0001402023","issuer_name":"Egalet Corp","issuer_ticker":"EGLT","issuer_name_source":null,"issuer_url":"/issuer/0001402023","owner_cik":null,"owner_name":"Index Ventures III (Delaware) L.P.; INDEX VENTURES LIFE VI (JERSEY) L.P.; Yucca (Jersey) SLP; Index Venture Associates III Ltd; Index Ventures III (Jersey) L.P.; Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.","owner_display_name":"Index Ventures III (Delaware) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":370833.0,"shares_display":"370,833","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4449996.0,"total_display":"4,449,996.00","total_whole":"4,449,996","shares_owned_after":1007033.0,"shares_owned_after_display":"1,007,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-11","filed_date":"2014-02-13","scope":"insider","n_lines":5},{"id":3429068,"accession":"0000904454-12-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-12-000040","line_url":"/filing/0000904454-12-000040#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":null,"owner_name":"Yucca Partners L.P. Jersey Branch; Index Venture Associates III Ltd; Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.; Index Ventures III (Delaware) L.P.; Index Ventures III (Jersey) L.P.","owner_display_name":"Yucca Partners L.P. Jersey Branch","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":17.08,"price_display":"17.08","price_state":"stated","total_value":854000.0,"total_display":"854,000.00","total_whole":"854,000","shares_owned_after":2081827.0,"shares_owned_after_display":"2,081,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-01-30","filed_date":"2012-02-01","scope":"insider"},{"id":8818231,"accession":"0000904454-11-000419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-11-000419","line_url":"/filing/0000904454-11-000419#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":null,"owner_name":"Index Ventures III (Delaware) L.P.; Yucca Partners L.P. Jersey Branch; Index Venture Associates III Ltd; Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.; Index Ventures III (Jersey) L.P.","owner_display_name":"Index Ventures III (Delaware) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36788.0,"shares_display":"36,788","price_per_share":14.6087,"price_display":"14.61","price_state":"stated","total_value":537424.8556,"total_display":"537,424.86","total_whole":"537,425","shares_owned_after":2131827.0,"shares_owned_after_display":"2,131,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-07-29","filed_date":"2011-08-02","scope":"insider"},{"id":9186814,"accession":"0000904454-11-000321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-11-000321","line_url":"/filing/0000904454-11-000321#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":null,"owner_name":"Yucca Partners L.P. Jersey Branch; Index Venture Associates III Ltd; Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.; Index Ventures III (Delaware) L.P.; Index Ventures III (Jersey) L.P.","owner_display_name":"Yucca Partners L.P. Jersey Branch","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":877723.0,"shares_display":"877,723","price_per_share":14.6087,"price_display":"14.61","price_state":"stated","total_value":12822391.9901,"total_display":"12,822,391.99","total_whole":"12,822,392","shares_owned_after":2168435.0,"shares_owned_after_display":"2,168,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-06-29","filed_date":"2011-07-01","scope":"insider"},{"id":7366587,"accession":"0001181431-10-052253","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-052253","line_url":"/filing/0001181431-10-052253#line-4","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":null,"owner_name":"Index Ventures III (Jersey) L.P.; Index Ventures III (Delaware) L.P.; Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.; Index Venture Associates III Ltd; Yucca Partners L.P. Jersey Branch","owner_display_name":"Index Ventures III (Jersey) L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":315789.0,"shares_display":"315,789","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":2999995.5,"total_display":"2,999,995.50","total_whole":"2,999,996","shares_owned_after":3041986.0,"shares_owned_after_display":"3,041,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001586105","name":"Egalet Corp","url":"/issuer/0001586105","role":"Ten percent owner","n_filings":1,"first_seen":"2014-02-13","last_seen":"2014-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Ten percent owner","n_filings":4,"first_seen":"2010-10-27","last_seen":"2012-02-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001503681","retrieved_at":"2026-08-23T13:51:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}